Allogeneic transplantation in primary refractory AML (Q87901185)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

title

Allogeneic transplantation in primary refractory AML (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

P Ferguson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

publication date

24 April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

18 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

page(s)

950-951

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json

Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia

18 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

Factors predicting outcome after allogeneic transplant in refractory acute myeloid leukemia: a retrospective analysis of Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

Primary refractory acute myeloid leukaemia - in search of better definitions and therapies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

Clinical Utility of Next-Generation Sequencing for Oncogenic Mutations in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

Mutational analysis of disease relapse in patients allografted for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

Long-term outcomes of alemtuzumab-based reduced-intensity conditioned hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myelogenous leukemia secondary to myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

High alloreactivity of low-dose prophylactic donor lymphocyte infusion in patients with acute leukemia undergoing allogeneic hematopoietic cell transplantation with an alemtuzumab-containing conditioning regimen.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

Ipilimumab for Patients with Relapse after Allogeneic Transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2017.61

7 January 2021

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28436972

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/BMT.2017.61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28436972%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

1 reference